查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726379

全球綜合代謝組檢測市場：市場規模、佔有率、趨勢分析（按分析目標、疾病、最終用途和地區）、細分市場預測（2025 年至 2030 年）

Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2), By Disease (Kidney Disease, Diabetes), By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

綜合代謝組測試市場的成長與趨勢：

根據 Grand View Research, Inc. 的新報告，全球綜合代謝組測試市場預計到 2030 年將達到 220.7 億美元，2025 年至 2030 年的複合年成長率為 9.5%。

糖尿病、腎臟疾病和心血管疾病等慢性疾病負擔的增加是市場成長的主要驅動力。

技術創新正在再形成診斷能力，自動化平台和照護現場設備提高了檢測速度、準確性和可訪問性。先進的系統現在正在整合人工智慧進行數據分析，從而能夠準確解釋結果和預測見解。

此外，預防保健意識的不斷增強正在改變醫療保健消費模式。公共衛生宣傳活動和政策舉措強調早期療育以控制長期成本，並鼓勵個人優先進行定期METABOLIC INC.篩檢。保險公司擴大將這些測試作為預防性護理計劃的一部分，從而增加了採用率。

綜合代謝組測試市場：分析概述

  • 預計 2024 年葡萄糖的銷售佔有率最大，為 11.0%。這是因為人們更重視早期發現和預防護理，以及久坐的生活方式和不良飲食等生活方式相關因素。
  • 由於腎臟疾病、心血管疾病和電解質失衡病例的增加需要準確監測 K+ 水平，預計預測期內 K+ 部分將以 10.0% 最快的複合年成長率成長。
  • 腎臟疾病將在全球綜合代謝組檢測市場中佔據主導地位，到 2024 年將佔據 32.4% 的最大收入佔有率。這主要是由於高血壓、糖尿病和肥胖症的發生率不斷上升，以及污染和過量攝取等環境因素。
  • 由於技術進步使得檢測更加準確和便捷，以及醫療保險對預防性篩檢的覆蓋範圍不斷擴大，糖尿病領域預計將以最快的速度成長，預測期內的複合年成長率為 10.3%。
  • 到 2024 年，實驗室領域將在收益佔有率方面佔據最大的市場主導地位。預計 PoC 領域將成長最快，2025 年至 2030 年的複合年成長率為 10.3%。
  • 預計到 2024 年，北美將佔據全球綜合代謝組檢測市場的最大收入佔有率，這主要是因為糖尿病、腎臟疾病和心血管疾病等慢性疾病的收益佔有率很高，需要進行常規代謝監測。
  • 全球綜合代謝組測試市場的一些主要企業包括雅培、Quest Diagnostics、Sonic Healthcare、Unipath、SYNLAB International GmbH 和 ARUP Laboratories。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章全球綜合代謝組測試市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 綜合代謝組測試市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析

第4章全球綜合代謝組測試市場：按分析類別的商業分析

  • 每個分析目標的儀表板
  • 綜合代謝組檢測市場：依分析目標進行變異分析
  • 全球綜合代謝組測試市場：按分析類型分類的市場規模和趨勢分析（2018-2030 年）
  • K+
  • 鈉
  • Cl-
  • CO2
  • 葡萄糖
  • 麵包
  • 肌酸酐
  • 鈣
  • 白蛋白
  • 總蛋白
  • ALP
  • 選擇
  • AST
  • 總膽紅素

第5章全球綜合代謝組測試市場：按疾病分類的業務分析

  • 疾病儀表板
  • 綜合代謝組檢測市場：依疾病進行變異分析
  • 全球綜合代謝組檢測市場：按疾病分類的市場規模和趨勢分析（2018-2030 年）
  • 腎臟疾病
  • 肝病
  • 糖尿病
  • 其他

6. 全球綜合代謝組測試市場：依最終用途的業務分析

  • 最終用途儀表板
  • 綜合代謝組檢測市場：變異分析（依最終用途）
  • 全球綜合代謝組測試市場：按最終用途分類的市場規模和趨勢分析（2018-2030 年）
  • 實驗室
  • 概念驗證
  • PoC（設備）

第7章全球綜合代謝組測試市場：按地區估計和趨勢分析

  • 市場儀表板：按地區
  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 全球綜合代謝組檢測市場：按地區分類的關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要企業熱力圖分析（2024年）
  • 公司簡介
    • Abbott
    • Quest Diagnostics
    • Laboratory Corporation of America Holdings Limited
    • Sonic Healthcare
    • Unipath
    • SYNLAB International GmbH
    • ARUP Laboratories
    • Genoptix Inc.
    • Nova Medical
Product Code: GVR-3-68038-747-6

Comprehensive Metabolic Panel Testing Market Growth & Trends:

The global comprehensive metabolic panel testing market is anticipated to reach USD 22.07 billion by 2030 and is expected to expand at a CAGR of 9.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising burden of chronic conditions such as diabetes, kidney disorders, and cardiovascular ailments is the major factor contributing to the market's growth.

Technological innovations are reshaping diagnostic capabilities, with automated platforms and point-of-care devices enhancing testing speed, accuracy, and accessibility. Advanced systems now integrate AI for data analysis, allowing precise interpretation of results and predictive insights.

Moreover, heightened awareness of preventive care is transforming healthcare consumption patterns. Public health campaigns and policy initiatives emphasize early intervention to curb long-term costs, prompting individuals to prioritize regular metabolic screenings. Insurers are increasingly covering these tests within preventive care packages, reinforcing their adoption.

Comprehensive Metabolic Panel Testing Market Report Highlights:

  • Glucose accounted for the largest revenue share of 11.0% in 2024, attributed to the increased emphasis on early detection and preventive healthcare, coupled with lifestyle-related factors such as sedentary habits and poor diets.
  • The K+ segment is expected to grow at the fastest CAGR of 10.0% over the forecast period, owing to rising cases of kidney diseases, cardiovascular disorders, and electrolyte imbalances requiring precise monitoring of K+ levels.
  • The kidney diseases dominated the global comprehensive metabolic panel testing market and accounted for the largest revenue share of 32.4% in 2024, primarily driven by increased incidence of hypertension, diabetes, and obesity, alongside environmental factors such as pollution and dietary salt overconsumption.
  • The diabetes segment is expected to grow at the fastest CAGR of 10.3% over the forecast period, due to technological advancements enabling precise, accessible testing and expanded health insurance coverage for preventive screenings
  • The laboratories segment held the dominant position in the market with the largest revenue share in 2024. The PoC segment is expected to grow at the fastest CAGR of 10.3% from 2025 to 2030.
  • North America dominated the global comprehensive metabolic panel testing market with the largest revenue share in 2024, primarily driven by the high prevalence of chronic diseases such as diabetes, kidney disorders, and cardiovascular conditions, necessitating routine metabolic monitoring.
  • Key companies operating in the global comprehensive metabolic panel testing market include Abbott, Quest Diagnostics, Sonic Healthcare, Unipath, SYNLAB International GmbH, ARUP Laboratories.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Analytes
    • 1.2.2. Disease
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Analytes Outlook
    • 2.2.2. Disease Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Comprehensive Metabolic Panel Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Comprehensive Metabolic Panel Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Comprehensive Metabolic Panel Testing Market: Analytes Business Analysis

  • 4.1. Analytes Segment Dashboard
  • 4.2. Comprehensive Metabolic Panel Testing Market: Analytes Movement Analysis
  • 4.3. Global Comprehensive Metabolic Panel Testing Market Size & Trend Analysis, By Analytes, 2018 to 2030 (USD Million)
  • 4.4. K+
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Na+
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Cl-
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.7. CO2
    • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.8. Glucose
    • 4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.9. BUN
    • 4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.10. Creatinine
    • 4.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.11. Ca++
    • 4.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.12. Albumin
    • 4.12.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.13. Total protein
    • 4.13.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.14. ALP
    • 4.14.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.15. ALT
    • 4.15.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.16. AST
    • 4.16.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.17. Total bilirubin
    • 4.17.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Comprehensive Metabolic Panel Testing Market: Disease Business Analysis

  • 5.1. Disease Segment Dashboard
  • 5.2. Comprehensive Metabolic Panel Testing Market: Disease Movement Analysis
  • 5.3. Global Comprehensive Metabolic Panel Testing Market Size & Trend Analysis, By Disease, 2018 to 2030 (USD Million)
  • 5.4. Kidney Disease
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Liver Disease
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Diabetes
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Comprehensive Metabolic Panel Testing Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Comprehensive Metabolic Panel Testing Market: End Use Movement Analysis
  • 6.3. Global Comprehensive Metabolic Panel Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Laboratory
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Emergency dept.
      • 6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Hospital wards
      • 6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Primary care
      • 6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Pharmacy
      • 6.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Telemedicine
      • 6.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. PoC
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Emergency dept.
      • 6.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Hospital wards
      • 6.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Primary care
      • 6.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Pharmacy
      • 6.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Telemedicine
      • 6.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. PoC (Instruments)
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Piccolo Xpress
      • 6.6.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Skyla-HB1
      • 6.6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.4. DRI-CHEM NX500
      • 6.6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Others
      • 6.6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Comprehensive Metabolic Panel Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Global Comprehensive Metabolic Panel Testing Market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Quest Diagnostics
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Laboratory Corporation of America Holdings Limited
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Sonic Healthcare
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Unipath
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. SYNLAB International GmbH
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. ARUP Laboratories
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Genoptix Inc.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Nova Medical
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiative

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 3 Global Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 4 Global Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Comprehensive Metabolic Panel Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 North America Comprehensive Metabolic Panel Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 8 North America Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 9 North America Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 11 U.S. Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 12 U.S. Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 14 Canada Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 15 Canada Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 17 Mexico Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 18 Mexico Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Comprehensive Metabolic Panel Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 21 Europe Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 22 Europe Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 23 Germany Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 24 Germany Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 25 Germany Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 UK Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 27 UK Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 28 UK Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29 France Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 30 France Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 31 France Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 33 Italy Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 34 Italy Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 36 Spain Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 37 Spain Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 39 Denmark Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 40 Denmark Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 42 Sweden Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 43 Sweden Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 45 Norway Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 46 Norway Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Comprehensive Metabolic Panel Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51 China Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 52 China Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 53 China Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 55 Japan Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 56 Japan Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 India Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 58 India Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 59 India Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 61 South Korea Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 62 South Korea Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63 Australia Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 64 Australia Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 65 Australia Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 67 Thailand Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 68 Thailand Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Comprehensive Metabolic Panel Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 71 Latin America Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 72 Latin America Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 74 Brazil Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 75 Argentina Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 76 Argentina Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 77 Argentina Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 MEA Comprehensive Metabolic Panel Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 79 MEA Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 80 MEA Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 81 MEA Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82 South Africa Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 83 South Africa Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 84 South Africa Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 UAE Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 89 UAE Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 90 UAE Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Comprehensive Metabolic Panel Testing Market: Market Outlook
  • Fig. 10 Comprehensive Metabolic Panel Testing Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Comprehensive Metabolic Panel Testing Market Driver Impact
  • Fig. 16 Comprehensive Metabolic Panel Testing Market Restraint Impact
  • Fig. 17 Comprehensive Metabolic Panel Testing Market Strategic Initiatives Analysis
  • Fig. 18 Comprehensive Metabolic Panel Testing Market: Analytes Movement Analysis
  • Fig. 19 Comprehensive Metabolic Panel Testing Market: Analytes Outlook and Key Takeaways
  • Fig. 20 K+ Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Na+ Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Cl- Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 CO2 Market Estimates and Forecast, 2018 - 2030
  • Fig. 24 Glucose Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 BUN Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Creatinine Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Ca++ Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Albumin Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Total protein Market Estimates and Forecast, 2018 - 2030
  • Fig. 30 ALP Market Estimates and Forecast, 2018 - 2030
  • Fig. 31 ALT Market Estimates and Forecast, 2018 - 2030
  • Fig. 32 AST Market Estimates and Forecast, 2018 - 2030
  • Fig. 33 Total bilirubin Market Estimates and Forecast, 2018 - 2030
  • Fig. 34 Comprehensive Metabolic Panel Testing Market: Disease Movement Analysis
  • Fig. 35 Comprehensive Metabolic Panel Testing Market: Disease Outlook and Key Takeaways
  • Fig. 36 Kidney Disease Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Liver Disease Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 Diabetes Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Comprehensive Metabolic Panel Testing Market: End Use Movement Analysis
  • Fig. 41 Comprehensive Metabolic Panel Testing Market: End Use Outlook and Key Takeaways
  • Fig. 42 Laboratory Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 PoC Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 PoC (Instruments) Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Global Comprehensive Metabolic Panel Testing Market: Regional Movement Analysis
  • Fig. 46 Global Comprehensive Metabolic Panel Testing Market: Regional Outlook and Key Takeaways
  • Fig. 47 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 69 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 71 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 72 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 73 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 74 Kuwait Market Estimates and Forecasts, 2018 - 2030